Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102354362 | 10235436 | 2 | F | 20160909 | 20140613 | 20160916 | EXP | IR-MYLANLABS-2014S1013514 | MYLAN | MAKHDOOMI K, MIVEFROSHAN A, RAHIMIRAD MH, RABEIPOOR M, ABBASI F, MOHAMMADI A, EISHEI OSKUEI A. DISSEMINATED KAPOSI^S SARCOMA. ARCHIVES OF IRANIAN MEDICINE 18: 793-5, NO. 11, NOV 2015 | 0.00 | Y | 0.00000 | 20160916 | IR | IR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102354362 | 10235436 | 1 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | 1000 MG, QD | D | 0 | 1000 | MG | QD | ||||||
| 102354362 | 10235436 | 2 | PS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 1 MG/KG, QD | U | 202179 | 1 | MG/KG | QD | ||||||
| 102354362 | 10235436 | 3 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | 5 MG, QD | U | 202179 | 5 | MG | QD | ||||||
| 102354362 | 10235436 | 4 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 102354362 | 10235436 | 5 | I | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | 6 MG/KG, UNK | D | 0 | 6 | MG/KG | |||||||
| 102354362 | 10235436 | 6 | I | CICLOSPORIN | CYCLOSPORINE | 1 | Unknown | 200 MG, QD (2.2 MG/KG) | D | 0 | 200 | MG | QD | ||||||
| 102354362 | 10235436 | 7 | I | GLIVEC | IMATINIB MESYLATE | 1 | Unknown | 200 MG, QD | 0 | 200 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102354362 | 10235436 | 1 | Immunosuppression |
| 102354362 | 10235436 | 2 | Immunosuppression |
| 102354362 | 10235436 | 4 | Immunosuppression |
| 102354362 | 10235436 | 5 | Immunosuppression |
| 102354362 | 10235436 | 7 | Chronic myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102354362 | 10235436 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102354362 | 10235436 | Blood creatinine increased | |
| 102354362 | 10235436 | Chronic myeloid leukaemia | |
| 102354362 | 10235436 | Drug interaction | |
| 102354362 | 10235436 | Kaposi's sarcoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |